2rgu
From Proteopedia
(Difference between revisions)
m (Protected "2rgu" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
[[Image:2rgu.png|left|200px]] | [[Image:2rgu.png|left|200px]] | ||
| - | <!-- | ||
| - | The line below this paragraph, containing "STRUCTURE_2rgu", creates the "Structure Box" on the page. | ||
| - | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
| - | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
| - | or leave the SCENE parameter empty for the default display. | ||
| - | --> | ||
{{STRUCTURE_2rgu| PDB=2rgu | SCENE= }} | {{STRUCTURE_2rgu| PDB=2rgu | SCENE= }} | ||
===Crystal structure of complex of human DPP4 and inhibitor=== | ===Crystal structure of complex of human DPP4 and inhibitor=== | ||
| - | |||
| - | <!-- | ||
| - | The line below this paragraph, {{ABSTRACT_PUBMED_18052023}}, adds the Publication Abstract to the page | ||
| - | (as it appears on PubMed at http://www.pubmed.gov), where 18052023 is the PubMed ID number. | ||
| - | --> | ||
{{ABSTRACT_PUBMED_18052023}} | {{ABSTRACT_PUBMED_18052023}} | ||
| Line 22: | Line 11: | ||
==See Also== | ==See Also== | ||
| - | *[[Dipeptidyl peptidase]] | + | *[[Dipeptidyl peptidase|Dipeptidyl peptidase]] |
==Reference== | ==Reference== | ||
| - | <ref group="xtra">PMID: | + | <ref group="xtra">PMID:018052023</ref><references group="xtra"/> |
[[Category: Dipeptidyl-peptidase IV]] | [[Category: Dipeptidyl-peptidase IV]] | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
Revision as of 15:06, 27 July 2012
Contents |
Crystal structure of complex of human DPP4 and inhibitor
Template:ABSTRACT PUBMED 18052023
About this Structure
2rgu is a 2 chain structure of Dipeptidyl peptidase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See Also
Reference
- Eckhardt M, Langkopf E, Mark M, Tadayyon M, Thomas L, Nar H, Pfrengle W, Guth B, Lotz R, Sieger P, Fuchs H, Himmelsbach F. 8-(3-(R)-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin -2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a highly potent, selective, long-acting, and orally bioavailable DPP-4 inhibitor for the treatment of type 2 diabetes. J Med Chem. 2007 Dec 27;50(26):6450-3. Epub 2007 Dec 1. PMID:18052023 doi:10.1021/jm701280z
